Cite
HARVARD Citation
Taghi Khani, A. et al. (n.d.). P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES. HemaSphere. pp. 1181-1182. [Online].